StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck cash and Cash Equivalents ($M) ($M)

Postgres DB financial_values

Latest, Q2 2026
6,849
Period ended Jun 30, 2026
Change on a year earlier
-15.2%
8,073 in Q2 2025
History
73 quarters
Since Q4 2006
Sources
56
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCash and Cash Equivalents ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20266,849-15.2%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 20265,327-39.0%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 202514,565+9.4%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 202518,169+23.7%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20258,073-29.0%Form 10-Q (filed 2026-08-07) ↗
Q1 2025Mar 31, 20258,732+54.0%Form 10-Q (filed 2026-05-04) ↗
Q4 2024Dec 31, 202413,318+92.8%Form 10-Q (filed 2026-05-04) ↗
Q3 2024Sep 30, 202414,688+69.4%Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 202411,373+99.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20245,671-42.0%Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 20236,909-45.9%Form 10-Q (filed 2025-05-02) ↗
Q3 2023Sep 30, 20238,669-23.1%Form 10-Q (filed 2024-11-06) ↗
Q2 2023Jun 30, 20235,712-41.4%Form 10-Q (filed 2024-08-05) ↗
Q1 2023Mar 31, 20239,786+13.6%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 202212,773+56.4%Form 10-Q (filed 2024-05-03) ↗
Q3 2022Sep 30, 202211,279+12.3%Form 10-Q (filed 2023-11-03) ↗

Cite this data

StockData. (2026). Merck Cash and Cash Equivalents ($M) ($M), quarterly Q4 2006–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_cash

See every metric in the Merck KPI table. Data updated Oct 26, 2026.